Isopimaric Acid Derivatives as Potential Dual PPARα/γ Agonists in the Treatment of Metabolic Syndrome › Research Explorer

Novosibirsk State University's Research Portal

Isopimaric Acid Derivatives as Potential Dual PPARα/γ Agonists in the Treatment of Metabolic Syndrome

Research output: Contribution to journal › Article › peer-review

Институт медицины и медицинских технологий

DOI

https://doi.org/10.3390/scipharm93030044
Final published version

Mikhail E. Blokhin
Sergey A. Borisov
Mariia A. Gromova
Yulia V. Meshkova
Nataliya A. Zhukova
Sophia V. Nikonova
Igor P. Zhurakovsky
Olga A. Luzina
Mikhail V. Khvostov
Dmitry A. Kudlay
Nariman F. Salakhutdinov

Original language	English
Article number	44
Journal	Scientia Pharmaceutica
Volume	93
Issue number	3
DOIs	https://doi.org/10.3390/scipharm93030044
Publication status	Published - 5 Sept 2025

OECD FOS+WOS

3.01.TU PHARMACOLOGY & PHARMACY

Research areas

hypoglycemic activity, isopimaric acid, metabolic syndrome, natural compounds, type 2 diabetes mellitus

ID: 70162787